Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News China Pharma Holdings Inc CPHI

Healthcare
China Pharma Holdings Inc is a company principally engaged in the development, manufacture and marketing of pharmaceutical products. The Company's products are for human use in connection, and with a variety of high-incidence and high-mortality diseases and medical conditions prevalent. The Company manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables... see more

Recent & Breaking News (NYSEAM:CPHI)

China Pharma Holdings Inc. Announces 1-for-5 Reverse Stock Split

PR Newswire February 23, 2024

China Pharma Holdings, Inc. Announced the Completion of Third Party Testing of Dry Eye Disease Therapeutic Device

PR Newswire November 29, 2023

China Pharma's Candesartan Hypertension Product Passes the Quality and Efficacy Consistency Evaluation of Generic Drugs

PR Newswire August 9, 2023

China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split

PR Newswire February 24, 2023

China Pharma Holdings, Inc. Announced the Launch of N95 Medical Protective Mask

PR Newswire December 28, 2022

China Pharma Holdings, Inc. Announced that several products are included in the Catalogue of Medicines for People Infected with COVID-19

PR Newswire December 15, 2022

China Pharma Holdings, Inc. Announced the Acquisition of Dry Eye Disease Therapeutic Device Project

PR Newswire December 5, 2022

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

PR Newswire December 2, 2022

China Pharma Announces Receipt of Notification of NYSE American Listing Deficiency

PR Newswire October 1, 2022

China Pharma Announced the Submission of a Plan of Compliance to NYSE American

PR Newswire July 18, 2022

China Pharma Announces Receipt of Noncompliance Notice from NYSE American

PR Newswire June 22, 2022

China Pharma Holdings, Inc. Reports Fiscal Year 2021 Financial Results

PR Newswire March 31, 2022

China Pharma Holdings, Inc. Reports Third Quarter 2021 Financial Results

PR Newswire November 12, 2021

China Pharma Holdings, Inc. Reports Second Quarter 2021 Financial Results

PR Newswire August 13, 2021

China Pharma's Candesartan Hypertension Product Passes Bioequivalence Tests and the Company Plans to Apply for NMPA Approval

PR Newswire August 5, 2021

China Pharma to Launch Highly Purified NMN+PQQ Product

PR Newswire June 9, 2021

China Pharma Holdings, Inc. Reports 33% YoY Increase in First Quarter 2021 Revenue

PR Newswire May 14, 2021

China Pharma Expects Considerable Increase in Growth Opportunities Related to Hainan Free Trade Port

PR Newswire April 19, 2021

China Pharma Holdings, Inc. Reports Fiscal Year 2020 Financial Results

PR Newswire March 26, 2021

China Pharma Holdings, Inc. Reports Third Quarter 2020 Financial Results

PR Newswire November 13, 2020